Fig. 3.
Elevated levels of circulating soluble Fas in sera of patients with LGL leukemia.
The concentration of soluble Fas in sera from patients with LGL leukemia (n = 30) was measured with a soluble Fas ELISA and compared to values measured in sera from healthy donors (n = 10). The horizontal lines indicate the mean value of the samples.